instruction stringlengths 226 748 | input stringlengths 159 2.15k | response stringlengths 3 12 |
|---|---|---|
<Instruct>: Given the context 'It is not present at the cell surface and is immunochemically and structurally distinct from the M(r) 175,000 mannose receptor of mature macrophages.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [m(r) 175,000 mannose receptor of mature macrophages]
<Options>: A: mannose receptor c-type 2 (homo sapiens) (aka mannose receptor c-type 2)
B: mannose receptor c-type 1 (homo sapiens) (aka mannose receptor c-type 1)
C: mannr (mus musculus) (aka mecom adjacent non-protein coding rna)
D: mannose receptor, c type 1 (mus musculus) (aka mannose receptor, c type 1)
E: mannose receptor, c type 2 (mus musculus) (aka mannose receptor, c type 2)
F: None of the above. | [B] |
<Instruct>: Given the context 'MR60 cDNA was isolated and characterized; on the basis of its sequence, MR60 is not related to any known mammalian lectins.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mr60]
<Options>: A: mrt60 (homo sapiens) (aka tata-box binding protein associated factor 13)
B: er60 (homo sapiens) (aka protein disulfide isomerase family a member 3)
C: mic60 (homo sapiens) (aka inner membrane mitochondrial protein)
D: mr60 (homo sapiens) (aka lectin, mannose binding 1)
E: ct60 (homo sapiens) (aka long intergenic non-protein coding rna 1193)
F: None of the above. | [D] |
<Instruct>: Given the context 'MR60 cDNA was isolated and characterized; on the basis of its sequence, MR60 is not related to any known mammalian lectins.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mr60]
<Options>: A: ct60 (homo sapiens) (aka long intergenic non-protein coding rna 1193)
B: mic60 (homo sapiens) (aka inner membrane mitochondrial protein)
C: mrt60 (homo sapiens) (aka tata-box binding protein associated factor 13)
D: er60 (homo sapiens) (aka protein disulfide isomerase family a member 3)
E: None of the above. | [E] |
<Instruct>: Given the context 'Surprisingly, MR60 was found to be identical to ERGIC-53 (Schindler, R., Itin, C., Zerial, M., Lottspeich, F., and Hauri, H.P. (1993)', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mr60; ergic-53]
<Options>: A: cg6060 (drosophila melanogaster) (aka uncharacterized protein)
B: ergic-32 (homo sapiens) (aka endoplasmic reticulum-golgi intermediate compartment 1)
C: mr60 (mus musculus) (aka lectin, mannose-binding, 1)
D: mrt60 (homo sapiens) (aka tata-box binding protein associated factor 13)
E: ergic53 (drosophila melanogaster) (aka ergic53)
F: mr60 (homo sapiens) (aka lectin, mannose binding 1)
G: er60 (homo sapiens) (aka protein disulfide isomerase family a member 3)
H: ergic-53 (xenopus tropicalis) (aka lectin, mannose binding 1)
I: ergic-53l (homo sapiens) (aka lectin, mannose binding 1 like)
J: None of the above. | [F; F] |
<Instruct>: Given the context 'Surprisingly, MR60 was found to be identical to ERGIC-53 (Schindler, R., Itin, C., Zerial, M., Lottspeich, F., and Hauri, H.P. (1993)', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mr60; ergic-53]
<Options>: A: mr60 (homo sapiens) (aka lectin, mannose binding 1)
B: ergic3 (homo sapiens) (aka ergic and golgi 3)
C: rad60 (homo sapiens) (aka nuclear factor of activated t cells 2 interacting protein)
D: mic60 (homo sapiens) (aka inner membrane mitochondrial protein)
E: er60 (homo sapiens) (aka protein disulfide isomerase family a member 3)
F: ergic-63 (homo sapiens) (aka cytoskeleton associated protein 4)
G: ergic-53l (mus musculus) (aka complexin 3)
H: ergic-53l (homo sapiens) (aka lectin, mannose binding 1 like)
I: hel60 (homo sapiens) (aka aconitase 1)
J: None of the above. | [A; A] |
<Instruct>: Given the context '61, 1-9), a type I integral membrane protein, defined as a marker of the intermediate compartment that recycles between the Golgi apparatus and endoplasmic reticulum; MR60/ERGIC-53 shares with VIP-36 significant homologies with leguminous plant lectins (Fiedler, K., and Simmons, K. (1994)', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mr60; ergic-53; vip-36]
<Options>: A: ergic-63 (homo sapiens) (aka cytoskeleton associated protein 4)
B: ergic-53l (mus musculus) (aka complexin 3)
C: ergic-32 (homo sapiens) (aka endoplasmic reticulum-golgi intermediate compartment 1)
D: vip32 (xenopus tropicalis) (aka arginine vasopressin induced 1)
E: mr60 (homo sapiens) (aka lectin, mannose binding 1)
F: vip36-like (mus musculus) (aka lectin, mannose-binding 2-like)
G: vip36 (homo sapiens) (aka lectin, mannose binding 2)
H: vip36 (xenopus tropicalis) (aka lectin, mannose-binding 2)
I: ro60 (homo sapiens) (aka ro60, y rna binding protein)
J: ergic-53l (homo sapiens) (aka lectin, mannose binding 1 like)
K: cg6060 (drosophila melanogaster) (aka uncharacterized protein)
L: hel60 (homo sapiens) (aka aconitase 1)
M: ct60 (homo sapiens) (aka long intergenic non-protein coding rna 1193)
N: vip36 (mus musculus) (aka lectin, mannose-binding 2)
O: None of the above. | [E; E; G] |
<Instruct>: Given the context '61, 1-9), a type I integral membrane protein, defined as a marker of the intermediate compartment that recycles between the Golgi apparatus and endoplasmic reticulum; MR60/ERGIC-53 shares with VIP-36 significant homologies with leguminous plant lectins (Fiedler, K., and Simmons, K. (1994)', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mr60; ergic-53; vip-36]
<Options>: A: icen-36 (homo sapiens) (aka centromere protein o)
B: vip36 (rattus norvegicus) (aka lectin, mannose-binding 2)
C: ergic-53 (xenopus tropicalis) (aka lectin, mannose binding 1)
D: ergic53 (drosophila melanogaster) (aka ergic53)
E: mr60 (homo sapiens) (aka lectin, mannose binding 1)
F: cg6060 (drosophila melanogaster) (aka uncharacterized protein)
G: mrt60 (homo sapiens) (aka tata-box binding protein associated factor 13)
H: vip36 (homo sapiens) (aka lectin, mannose binding 2)
I: ro60 (homo sapiens) (aka ro60, y rna binding protein)
J: vacuolar protein sorting 36 homolog (xenopus tropicalis) (aka vacuolar protein sorting 36 homolog)
K: ergic-53l (mus musculus) (aka complexin 3)
L: rad60 (homo sapiens) (aka nuclear factor of activated t cells 2 interacting protein)
M: vip32 (xenopus tropicalis) (aka arginine vasopressin induced 1)
N: ergic-32 (homo sapiens) (aka endoplasmic reticulum-golgi intermediate compartment 1)
O: None of the above. | [E; E; H] |
<Instruct>: Given the context '61, 1-9), a type I integral membrane protein, defined as a marker of the intermediate compartment that recycles between the Golgi apparatus and endoplasmic reticulum; MR60/ERGIC-53 shares with VIP-36 significant homologies with leguminous plant lectins (Fiedler, K., and Simmons, K. (1994)', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mr60; ergic-53; vip-36]
<Options>: A: ergic53 (drosophila melanogaster) (aka ergic53)
B: cg6060 (drosophila melanogaster) (aka uncharacterized protein)
C: ergic-53 (xenopus tropicalis) (aka lectin, mannose binding 1)
D: vip32 (xenopus tropicalis) (aka arginine vasopressin induced 1)
E: vip36 (homo sapiens) (aka lectin, mannose binding 2)
F: icen-36 (homo sapiens) (aka centromere protein o)
G: vip36 (rattus norvegicus) (aka lectin, mannose-binding 2)
H: ergic-53l (mus musculus) (aka complexin 3)
I: ro60 (homo sapiens) (aka ro60, y rna binding protein)
J: rad60 (homo sapiens) (aka nuclear factor of activated t cells 2 interacting protein)
K: mrt60 (homo sapiens) (aka tata-box binding protein associated factor 13)
L: ergic-32 (homo sapiens) (aka endoplasmic reticulum-golgi intermediate compartment 1)
M: vacuolar protein sorting 36 homolog (xenopus tropicalis) (aka vacuolar protein sorting 36 homolog)
N: None of the above. | [N; N; E] |
<Instruct>: Given the context '61, 1-9), a type I integral membrane protein, defined as a marker of the intermediate compartment that recycles between the Golgi apparatus and endoplasmic reticulum; MR60/ERGIC-53 shares with VIP-36 significant homologies with leguminous plant lectins (Fiedler, K., and Simmons, K. (1994)', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mr60; ergic-53; vip-36]
<Options>: A: vip36 (mus musculus) (aka lectin, mannose-binding 2)
B: vip36 (homo sapiens) (aka lectin, mannose binding 2)
C: vip36 (rattus norvegicus) (aka lectin, mannose-binding 2)
D: mrt60 (homo sapiens) (aka tata-box binding protein associated factor 13)
E: vip36 (xenopus tropicalis) (aka lectin, mannose-binding 2)
F: ergic3 (homo sapiens) (aka ergic and golgi 3)
G: ergic-53 (xenopus tropicalis) (aka lectin, mannose binding 1)
H: hel60 (homo sapiens) (aka aconitase 1)
I: rad60 (homo sapiens) (aka nuclear factor of activated t cells 2 interacting protein)
J: ergic-63 (homo sapiens) (aka cytoskeleton associated protein 4)
K: mr60 (homo sapiens) (aka lectin, mannose binding 1)
L: ergic-32 (homo sapiens) (aka endoplasmic reticulum-golgi intermediate compartment 1)
M: vip32 (xenopus tropicalis) (aka arginine vasopressin induced 1)
N: mr60 (mus musculus) (aka lectin, mannose-binding, 1)
O: None of the above. | [K; K; B] |
<Instruct>: Given the context 'We extend these findings in evidencing a structural homology between MR60/ERGIC-53 and mammalian galectins (soluble beta galactose binding proteins).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mr60; ergic-53]
<Options>: A: ergic-63 (homo sapiens) (aka cytoskeleton associated protein 4)
B: rad60 (homo sapiens) (aka nuclear factor of activated t cells 2 interacting protein)
C: er60 (homo sapiens) (aka protein disulfide isomerase family a member 3)
D: cg6060 (drosophila melanogaster) (aka uncharacterized protein)
E: mr60 (homo sapiens) (aka lectin, mannose binding 1)
F: ergic-53l (mus musculus) (aka complexin 3)
G: ergic-53l (homo sapiens) (aka lectin, mannose binding 1 like)
H: mic60 (homo sapiens) (aka inner membrane mitochondrial protein)
I: ergic3 (homo sapiens) (aka ergic and golgi 3)
J: None of the above. | [E; E] |
<Instruct>: Given the context 'We extend these findings in evidencing a structural homology between MR60/ERGIC-53 and mammalian galectins (soluble beta galactose binding proteins).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mr60; ergic-53]
<Options>: A: mic60 (homo sapiens) (aka inner membrane mitochondrial protein)
B: ergic-63 (homo sapiens) (aka cytoskeleton associated protein 4)
C: er60 (homo sapiens) (aka protein disulfide isomerase family a member 3)
D: ro60 (homo sapiens) (aka ro60, y rna binding protein)
E: mr60 (homo sapiens) (aka lectin, mannose binding 1)
F: ergic53 (drosophila melanogaster) (aka ergic53)
G: ergic3 (homo sapiens) (aka ergic and golgi 3)
H: ergic-53l (xenopus tropicalis) (aka lectin, mannose-binding, 1 like)
I: hel60 (homo sapiens) (aka aconitase 1)
J: None of the above. | [E; E] |
<Instruct>: Given the context 'MR60/ERGIC-53 is the first lectin characterized as an endoplasmic reticulum-Golgi protein.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mr60; ergic-53]
<Options>: A: er60 (homo sapiens) (aka protein disulfide isomerase family a member 3)
B: hel60 (homo sapiens) (aka aconitase 1)
C: ergic-63 (homo sapiens) (aka cytoskeleton associated protein 4)
D: ergic3 (homo sapiens) (aka ergic and golgi 3)
E: mr60 (homo sapiens) (aka lectin, mannose binding 1)
F: mic60 (homo sapiens) (aka inner membrane mitochondrial protein)
G: ergic-53l (homo sapiens) (aka lectin, mannose binding 1 like)
H: ergic-53l (mus musculus) (aka complexin 3)
I: mr60 (mus musculus) (aka lectin, mannose-binding, 1)
J: None of the above. | [E; E] |
<Instruct>: Given the context 'MR60/ERGIC-53 is the first lectin characterized as an endoplasmic reticulum-Golgi protein.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mr60; ergic-53]
<Options>: A: mic60 (homo sapiens) (aka inner membrane mitochondrial protein)
B: mr60 (homo sapiens) (aka lectin, mannose binding 1)
C: ergic53 (drosophila melanogaster) (aka ergic53)
D: rad60 (homo sapiens) (aka nuclear factor of activated t cells 2 interacting protein)
E: ergic-53l (xenopus tropicalis) (aka lectin, mannose-binding, 1 like)
F: ergic3 (homo sapiens) (aka ergic and golgi 3)
G: mrt60 (homo sapiens) (aka tata-box binding protein associated factor 13)
H: mr60 (mus musculus) (aka lectin, mannose-binding, 1)
I: ergic-53 (xenopus tropicalis) (aka lectin, mannose binding 1)
J: None of the above. | [B; B] |
<Instruct>: Given the context 'Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [type 1 tumor necrosis factor receptor]
<Options>: A: dcr1-tnfr (homo sapiens) (aka tnf receptor superfamily member 10c)
B: tnfbr (homo sapiens) (aka tnf receptor superfamily member 1b)
C: tnfcr (homo sapiens) (aka lymphotoxin beta receptor)
D: tnf receptor superfamily member 1a (homo sapiens) (aka tnf receptor superfamily member 1a)
E: None of the above. | [D] |
<Instruct>: Given the context 'The yeast-based two hybrid has been used to identify a novel protein that binds to the intracellular domain of the type 1 receptor for tumor necrosis factor (TNFR-1IC).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [type 1 receptor for tumor necrosis factor; tnfr-1ic]
<Options>: A: tnfr-rp (homo sapiens) (aka lymphotoxin beta receptor)
B: tnfbr (homo sapiens) (aka tnf receptor superfamily member 1b)
C: tnfar (homo sapiens) (aka tnf receptor superfamily member 1a)
D: tnfr-1 (rattus norvegicus) (aka tnf receptor superfamily member 1a)
E: tnf receptor superfamily member 10c (homo sapiens) (aka tnf receptor superfamily member 10c)
F: tnfcr (homo sapiens) (aka lymphotoxin beta receptor)
G: tnf-r-ii (homo sapiens) (aka tnf receptor superfamily member 1b)
H: None of the above. | [C; C] |
<Instruct>: Given the context 'The yeast-based two hybrid has been used to identify a novel protein that binds to the intracellular domain of the type 1 receptor for tumor necrosis factor (TNFR-1IC).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [type 1 receptor for tumor necrosis factor; tnfr-1ic]
<Options>: A: tnfr-1 (rattus norvegicus) (aka tnf receptor superfamily member 1a)
B: tnf receptor superfamily member 10c (homo sapiens) (aka tnf receptor superfamily member 10c)
C: tnfbr (homo sapiens) (aka tnf receptor superfamily member 1b)
D: tnf receptor superfamily member 1b (homo sapiens) (aka tnf receptor superfamily member 1b)
E: tnfrsf1a (homo sapiens) (aka tnf receptor superfamily member 1a)
F: tnfr-rp (homo sapiens) (aka lymphotoxin beta receptor)
G: tnfcr (homo sapiens) (aka lymphotoxin beta receptor)
H: None of the above. | [E; E] |
<Instruct>: Given the context 'The TNF receptor-associated protein, TRAP-1, shows strong homology to members of the 90-kDa family of heat shock proteins.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [tnf receptor-associated protein; trap-1]
<Options>: A: trap150 (homo sapiens) (aka thyroid hormone receptor associated protein 3)
B: trap1 (homo sapiens) (tnf receptor associated protein 1 (homo sapiens)) (aka tnf receptor associated protein 1)
C: tnf receptor associated factor 5 (homo sapiens) (aka tnf receptor associated factor 5)
D: trap100 (homo sapiens) (aka mediator complex subunit 24)
E: trap-1 (bos taurus) (aka transforming growth factor beta receptor associated protein 1)
F: tnf receptor associated factor 7 (homo sapiens) (aka tnf receptor associated factor 7)
G: trapa (homo sapiens) (aka signal sequence receptor subunit 1)
H: tnf receptor associated factor (traf) homolog (caenorhabditis elegans) (aka tnf receptor associated factor (traf) homolog)
I: tnf receptor associated factor 1 (homo sapiens) (aka tnf receptor associated factor 1)
J: trap-1 (homo sapiens) (tnf receptor associated protein 1 (homo sapiens)) (aka tnf receptor associated protein 1)
K: None of the above. | [K; K] |
<Instruct>: Given the context 'The TNF receptor-associated protein, TRAP-1, shows strong homology to members of the 90-kDa family of heat shock proteins.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [tnf receptor-associated protein; trap-1]
<Options>: A: tnf receptor associated protein 1 (bos taurus) (aka tnf receptor associated protein 1)
B: tnf receptor associated protein 1 (homo sapiens) (aka tnf receptor associated protein 1)
C: trap-1 (bos taurus) (aka transforming growth factor beta receptor associated protein 1)
D: tnf receptor associated factor 1 (homo sapiens) (aka tnf receptor associated factor 1)
E: trap-1 (homo sapiens) (transforming growth factor beta receptor associated protein 1 (homo sapiens)) (aka transforming growth factor beta receptor associated protein 1)
F: tnf receptor associated factor 6 (homo sapiens) (aka tnf receptor associated factor 6)
G: tnf receptor associated factor 7 (homo sapiens) (aka tnf receptor associated factor 7)
H: tnf receptor-associated protein 1 (xenopus tropicalis) (aka tnf receptor-associated protein 1)
I: trap100 (homo sapiens) (aka mediator complex subunit 24)
J: trap95 (homo sapiens) (aka mediator complex subunit 16)
K: None of the above. | [K; K] |
<Instruct>: Given the context 'After in vitro transcription/translation and 35S labeling, TRAP-1 was precipitated using a fusion protein consisting of glutathione S-transferase and TNFR-1IC, showing that the two proteins directly interact.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [trap-1; tnfr-1ic]
<Options>: A: tnf-r-iii (homo sapiens) (aka lymphotoxin beta receptor)
B: trapa (homo sapiens) (aka signal sequence receptor subunit 1)
C: tnfbr (homo sapiens) (aka tnf receptor superfamily member 1b)
D: tnf receptor associated protein 1 (homo sapiens) (aka tnf receptor associated protein 1)
E: trap1 (homo sapiens) (transforming growth factor beta receptor associated protein 1 (homo sapiens)) (aka transforming growth factor beta receptor associated protein 1)
F: tnf-r-i (homo sapiens) (aka tnf receptor superfamily member 1a)
G: trap-1 (bos taurus) (aka transforming growth factor beta receptor associated protein 1)
H: trap95 (homo sapiens) (aka mediator complex subunit 16)
I: tnf receptor superfamily member 10c (homo sapiens) (aka tnf receptor superfamily member 10c)
J: None of the above. | [J; F] |
<Instruct>: Given the context 'After in vitro transcription/translation and 35S labeling, TRAP-1 was precipitated using a fusion protein consisting of glutathione S-transferase and TNFR-1IC, showing that the two proteins directly interact.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [trap-1; tnfr-1ic]
<Options>: A: tnfbr (homo sapiens) (aka tnf receptor superfamily member 1b)
B: tnf receptor superfamily member 10c (homo sapiens) (aka tnf receptor superfamily member 10c)
C: trap100 (homo sapiens) (aka mediator complex subunit 24)
D: trap95 (homo sapiens) (aka mediator complex subunit 16)
E: trap-1 (bos taurus) (aka transforming growth factor beta receptor associated protein 1)
F: tnf-r-iii (homo sapiens) (aka lymphotoxin beta receptor)
G: tnf-r (homo sapiens) (aka tnf receptor superfamily member 1a)
H: trap150 (homo sapiens) (aka thyroid hormone receptor associated protein 3)
I: trapa (homo sapiens) (aka signal sequence receptor subunit 1)
J: None of the above. | [J; G] |
<Instruct>: Given the context 'The ability of deletion mutants of TNFR-1 to interact with TRAP-1 was tested using the two hybrid system.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [tnfr-1; trap-1]
<Options>: A: trap100 (homo sapiens) (aka mediator complex subunit 24)
B: trap95 (homo sapiens) (aka mediator complex subunit 16)
C: trap-1 (bos taurus) (aka transforming growth factor beta receptor associated protein 1)
D: trap-1 (homo sapiens) (transforming growth factor beta receptor associated protein 1 (homo sapiens)) (aka transforming growth factor beta receptor associated protein 1)
E: tnfcr (homo sapiens) (aka lymphotoxin beta receptor)
F: trap150 (homo sapiens) (aka thyroid hormone receptor associated protein 3)
G: tnfr1 (homo sapiens) (aka tnf receptor superfamily member 1a)
H: tnfbr (homo sapiens) (aka tnf receptor superfamily member 1b)
I: None of the above. | [G; I] |
<Instruct>: Given the context 'The ability of deletion mutants of TNFR-1 to interact with TRAP-1 was tested using the two hybrid system.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [tnfr-1; trap-1]
<Options>: A: trap-1 (homo sapiens) (transforming growth factor beta receptor associated protein 1 (homo sapiens)) (aka transforming growth factor beta receptor associated protein 1)
B: trap95 (homo sapiens) (aka mediator complex subunit 16)
C: tnfrsf1a (homo sapiens) (aka tnf receptor superfamily member 1a)
D: trap-1 (bos taurus) (aka transforming growth factor beta receptor associated protein 1)
E: tnf receptor superfamily member 1b (homo sapiens) (aka tnf receptor superfamily member 1b)
F: tnfcr (homo sapiens) (aka lymphotoxin beta receptor)
G: trap100 (homo sapiens) (aka mediator complex subunit 24)
H: tnf receptor associated protein 1 (homo sapiens) (aka tnf receptor associated protein 1)
I: None of the above. | [C; I] |
<Instruct>: Given the context 'This showed that the amino acid sequences that mediate binding are diffusely distributed outside of the domain in the C terminus of TNFR-1IC that signals cytotoxicity.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [tnfr-1ic]
<Options>: A: tnf receptor superfamily member 10c (homo sapiens) (aka tnf receptor superfamily member 10c)
B: tnf-r (homo sapiens) (aka tnf receptor superfamily member 1a)
C: tnf-r-iii (homo sapiens) (aka lymphotoxin beta receptor)
D: tnfbr (homo sapiens) (aka tnf receptor superfamily member 1b)
E: None of the above. | [B] |
<Instruct>: Given the context 'The 2.4-kilobase TRAP-1 mRNA was variably expressed in skeletal muscle, liver, heart, brain, kidney, pancreas, lung, and placenta.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [trap-1]
<Options>: A: trap150 (homo sapiens) (aka thyroid hormone receptor associated protein 3)
B: tnf receptor associated protein 1 (homo sapiens) (aka tnf receptor associated protein 1)
C: trap1 (homo sapiens) (transforming growth factor beta receptor associated protein 1 (homo sapiens)) (aka transforming growth factor beta receptor associated protein 1)
D: trap-1 (bos taurus) (aka transforming growth factor beta receptor associated protein 1)
E: trap95 (homo sapiens) (aka mediator complex subunit 16)
F: None of the above. | [F] |
<Instruct>: Given the context 'TRAP-1 mRNA was also detected in each of eight different transformed cell lines.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [trap-1]
<Options>: A: trap95 (homo sapiens) (aka mediator complex subunit 16)
B: trap-1 (bos taurus) (aka transforming growth factor beta receptor associated protein 1)
C: trap100 (homo sapiens) (aka mediator complex subunit 24)
D: trapa (homo sapiens) (aka signal sequence receptor subunit 1)
E: trap1 (homo sapiens) (transforming growth factor beta receptor associated protein 1 (homo sapiens)) (aka transforming growth factor beta receptor associated protein 1)
F: None of the above. | [F] |
<Instruct>: Given the context 'Identification of TRAP-1 may be an important step toward defining how TNFR-1, which does not contain protein tyrosine kinase activity, transmits its message to signal transduction pathways.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [trap-1; tnfr-1]
<Options>: A: tnfrsf1a (homo sapiens) (aka tnf receptor superfamily member 1a)
B: trap95 (homo sapiens) (aka mediator complex subunit 16)
C: trap150 (homo sapiens) (aka thyroid hormone receptor associated protein 3)
D: trap1 (homo sapiens) (tnf receptor associated protein 1 (homo sapiens)) (aka tnf receptor associated protein 1)
E: tnf receptor superfamily member 1b (homo sapiens) (aka tnf receptor superfamily member 1b)
F: trap-1 (homo sapiens) (transforming growth factor beta receptor associated protein 1 (homo sapiens)) (aka transforming growth factor beta receptor associated protein 1)
G: trapa (homo sapiens) (aka signal sequence receptor subunit 1)
H: tnfr-rp (homo sapiens) (aka lymphotoxin beta receptor)
I: None of the above. | [I; A] |
<Instruct>: Given the context 'Identification of TRAP-1 may be an important step toward defining how TNFR-1, which does not contain protein tyrosine kinase activity, transmits its message to signal transduction pathways.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [trap-1; tnfr-1]
<Options>: A: tnf receptor associated protein 1 (homo sapiens) (aka tnf receptor associated protein 1)
B: trap-1 (homo sapiens) (transforming growth factor beta receptor associated protein 1 (homo sapiens)) (aka transforming growth factor beta receptor associated protein 1)
C: tnfar (homo sapiens) (aka tnf receptor superfamily member 1a)
D: trap100 (homo sapiens) (aka mediator complex subunit 24)
E: trap95 (homo sapiens) (aka mediator complex subunit 16)
F: tnfr-rp (homo sapiens) (aka lymphotoxin beta receptor)
G: tnfbr (homo sapiens) (aka tnf receptor superfamily member 1b)
H: trap-1 (bos taurus) (aka transforming growth factor beta receptor associated protein 1)
I: None of the above. | [I; C] |
<Instruct>: Given the context 'Expression and kinetic characterization of recombinant human stomach alcohol dehydrogenase.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [stomach alcohol dehydrogenase]
<Options>: A: alcohol dehydrogenase 6 (class v) (homo sapiens) (aka alcohol dehydrogenase 6 (class v))
B: alcohol dehydrogenase 6a (class v) (rattus norvegicus) (aka alcohol dehydrogenase 6a (class v))
C: adh1a (homo sapiens) (aka alcohol dehydrogenase 1a (class i), alpha polypeptide)
D: adh7 (homo sapiens) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
E: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (rattus norvegicus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
F: None of the above. | [D] |
<Instruct>: Given the context 'A full-length 1966-base pair clone of the human class IV alcohol dehydrogenase (sigma-ADH) was isolated from a human stomach cDNA library.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [class iv alcohol dehydrogenase; sigma-adh]
<Options>: A: alcohol dehydrogenase 4 (class ii), pi polypeptide (rattus norvegicus) (aka alcohol dehydrogenase 4 (class ii), pi polypeptide)
B: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (mus musculus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
C: alcohol dehydrogenase adh1 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh1)
D: alcohol dehydrogenase adh4 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh4)
E: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (rattus norvegicus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
F: alcohol dehydrogenase 1a (class i), alpha polypeptide (homo sapiens) (aka alcohol dehydrogenase 1a (class i), alpha polypeptide)
G: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (homo sapiens) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
H: adh4 (homo sapiens) (alcohol dehydrogenase 4 (class ii), pi polypeptide (homo sapiens)) (aka alcohol dehydrogenase 4 (class ii), pi polypeptide)
I: None of the above. | [G; G] |
<Instruct>: Given the context 'A full-length 1966-base pair clone of the human class IV alcohol dehydrogenase (sigma-ADH) was isolated from a human stomach cDNA library.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [class iv alcohol dehydrogenase; sigma-adh]
<Options>: A: alcohol dehydrogenase 6 (class v) (rattus norvegicus) (aka alcohol dehydrogenase 6 (class v))
B: alcohol dehydrogenase adh3 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh3)
C: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (rattus norvegicus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
D: alcohol dehydrogenase adh5 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh5)
E: alcohol dehydrogenase 6a (class v) (rattus norvegicus) (aka alcohol dehydrogenase 6a (class v))
F: alcohol dehydrogenase adh4 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh4)
G: adh4 (homo sapiens) (alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (homo sapiens)) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
H: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (mus musculus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
I: None of the above. | [G; G] |
<Instruct>: Given the context 'A full-length 1966-base pair clone of the human class IV alcohol dehydrogenase (sigma-ADH) was isolated from a human stomach cDNA library.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [class iv alcohol dehydrogenase; sigma-adh]
<Options>: A: alcohol dehydrogenase adh5 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh5)
B: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (rattus norvegicus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
C: alcohol dehydrogenase adh3 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh3)
D: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (mus musculus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
E: alcohol dehydrogenase 6 (class v) (rattus norvegicus) (aka alcohol dehydrogenase 6 (class v))
F: alcohol dehydrogenase 6a (class v) (rattus norvegicus) (aka alcohol dehydrogenase 6a (class v))
G: alcohol dehydrogenase adh4 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh4)
H: None of the above. | [H; H] |
<Instruct>: Given the context 'The 373-amino acid sigma-ADH encoded by this cDNA was expressed in Escherichia coli.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [sigma-adh]
<Options>: A: alcohol dehydrogenase adh1 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh1)
B: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (mus musculus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
C: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (homo sapiens) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
D: alcohol dehydrogenase 1a (class i), alpha polypeptide (homo sapiens) (aka alcohol dehydrogenase 1a (class i), alpha polypeptide)
E: alcohol dehydrogenase adh3 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh3)
F: None of the above. | [C] |
<Instruct>: Given the context 'Kinetic analysis of the catalytic efficiency (kcat/KM) of recombinant sigma-ADH for oxidation of primary alcohols indicated broad substrate specificity.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [sigma-adh]
<Options>: A: alcohol dehydrogenase adh2 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh2)
B: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (mus musculus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
C: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (homo sapiens) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
D: alcohol dehydrogenase adh3 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh3)
E: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (rattus norvegicus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
F: None of the above. | [C] |
<Instruct>: Given the context 'Recombinant human sigma-ADH exhibited high catalytic efficiency for oxidation of all-trans-retinol to all-trans-retinal.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [sigma-adh]
<Options>: A: adh1 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh1)
B: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (mus musculus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
C: alcohol dehydrogenase adh2 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh2)
D: alcohol dehydrogenase 1a (class i), alpha polypeptide (homo sapiens) (aka alcohol dehydrogenase 1a (class i), alpha polypeptide)
E: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (homo sapiens) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
F: None of the above. | [E] |
<Instruct>: Given the context 'Secondary alcohols and 3 beta-hydroxysteroids were inactive with sigma-ADH or were oxidized with very low efficiency.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [sigma-adh]
<Options>: A: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (rattus norvegicus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
B: alcohol dehydrogenase 1a (class i), alpha polypeptide (homo sapiens) (aka alcohol dehydrogenase 1a (class i), alpha polypeptide)
C: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (homo sapiens) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
D: alcohol dehydrogenase adh5 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh5)
E: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (mus musculus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
F: None of the above. | [C] |
<Instruct>: Given the context 'The KM of sigma-ADH for ethanol was 25 mM, and the KM for primary straight chain alcohols decreased substantially as chain length increased.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [sigma-adh]
<Options>: A: alcohol dehydrogenase adh3 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh3)
B: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (homo sapiens) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
C: alcohol dehydrogenase adh2 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh2)
D: alcohol dehydrogenase 1a (class i), alpha polypeptide (homo sapiens) (aka alcohol dehydrogenase 1a (class i), alpha polypeptide)
E: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (rattus norvegicus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
F: None of the above. | [B] |
<Instruct>: Given the context 'There are important amino acid differences in the alcohol-binding site between the human class IV (sigma) and human class I (beta) alcohol dehydrogenases that appear to explain the high catalytic efficiency for all-trans-retinol, the high kcat for ethanol, and the low catalytic efficiency for secondary alcohols of sigma-ADH relative to beta 1-ADH.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [class iv (sigma); class i (beta) alcohol dehydrogenases; sigma-adh; beta 1-adh]
<Options>: A: sigma1c (homo sapiens) (aka adaptor related protein complex 1 subunit sigma 3)
B: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (homo sapiens) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
C: adh1b (homo sapiens) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
D: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (rattus norvegicus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
E: adh4 (homo sapiens) (alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (homo sapiens)) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
F: alcohol dehydrogenase 1b (class i), beta polypeptide (bos taurus) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
G: alcohol dehydrogenase adh3 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh3)
H: adh1b promoter (homo sapiens) (aka adh1b promoter)
I: sigma3b (homo sapiens) (aka adaptor related protein complex 3 subunit sigma 2)
J: adh1c (homo sapiens) (aka alcohol dehydrogenase 1c (class i), gamma polypeptide)
K: alcohol dehydrogenase 1a (class i), alpha polypeptide (homo sapiens) (aka alcohol dehydrogenase 1a (class i), alpha polypeptide)
L: alcohol dehydrogenase 1b (class i), beta polypeptide (xenopus tropicalis) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
M: sigma3a (homo sapiens) (aka adaptor related protein complex 3 subunit sigma 1)
N: alcohol dehydrogenase adh2 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh2)
O: alcohol dehydrogenase adh5 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh5)
P: alcohol dehydrogenase 4 (class ii), pi polypeptide (homo sapiens) (aka alcohol dehydrogenase 4 (class ii), pi polypeptide)
Q: sigma1a (homo sapiens) (aka adaptor related protein complex 1 subunit sigma 1)
R: sigma5 (mus musculus) (aka adaptor-related protein 5 complex, sigma 1 subunit)
S: None of the above. | [E; C; E; C] |
<Instruct>: Given the context 'There are important amino acid differences in the alcohol-binding site between the human class IV (sigma) and human class I (beta) alcohol dehydrogenases that appear to explain the high catalytic efficiency for all-trans-retinol, the high kcat for ethanol, and the low catalytic efficiency for secondary alcohols of sigma-ADH relative to beta 1-ADH.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [class iv (sigma); class i (beta) alcohol dehydrogenases; sigma-adh; beta 1-adh]
<Options>: A: sigma3b (homo sapiens) (aka adaptor related protein complex 3 subunit sigma 2)
B: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (homo sapiens) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
C: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (mus musculus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
D: sigma5 (mus musculus) (aka adaptor-related protein 5 complex, sigma 1 subunit)
E: adh1a (homo sapiens) (aka alcohol dehydrogenase 1a (class i), alpha polypeptide)
F: alcohol dehydrogenase adh5 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh5)
G: adh1b promoter (homo sapiens) (aka adh1b promoter)
H: sigma1a (homo sapiens) (aka adaptor related protein complex 1 subunit sigma 1)
I: adh1b (bos taurus) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
J: sigma1c (homo sapiens) (aka adaptor related protein complex 1 subunit sigma 3)
K: ap-1 complex subunit sigma-1 (glycine max) (aka ap-1 complex subunit sigma-1)
L: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (rattus norvegicus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
M: alcohol dehydrogenase adh2 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh2)
N: adh1c (homo sapiens) (aka alcohol dehydrogenase 1c (class i), gamma polypeptide)
O: alcohol dehydrogenase 1b (class i), beta polypeptide (xenopus tropicalis) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
P: adh1b (homo sapiens) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
Q: None of the above. | [B; P; B; P] |
<Instruct>: Given the context 'There are important amino acid differences in the alcohol-binding site between the human class IV (sigma) and human class I (beta) alcohol dehydrogenases that appear to explain the high catalytic efficiency for all-trans-retinol, the high kcat for ethanol, and the low catalytic efficiency for secondary alcohols of sigma-ADH relative to beta 1-ADH.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [class iv (sigma); class i (beta) alcohol dehydrogenases; sigma-adh; beta 1-adh]
<Options>: A: alcohol dehydrogenase adh2 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh2)
B: 14-3-3 protein sigma-like (rattus norvegicus) (aka 14-3-3 protein sigma-like)
C: sigma1b (homo sapiens) (aka adaptor related protein complex 1 subunit sigma 2)
D: alcohol dehydrogenase adh3 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh3)
E: adh4 (homo sapiens) (alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (homo sapiens)) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
F: ap-1 complex subunit sigma-1 (glycine max) (aka ap-1 complex subunit sigma-1)
G: alcohol dehydrogenase 1b (class i), beta polypeptide (bos taurus) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
H: adh1b (homo sapiens) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
I: adh1a (homo sapiens) (aka alcohol dehydrogenase 1a (class i), alpha polypeptide)
J: sigma5 (mus musculus) (aka adaptor-related protein 5 complex, sigma 1 subunit)
K: adh1b promoter (homo sapiens) (aka adh1b promoter)
L: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (rattus norvegicus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
M: sigma1c (homo sapiens) (aka adaptor related protein complex 1 subunit sigma 3)
N: alcohol dehydrogenase 1a (class i), alpha polypeptide (homo sapiens) (aka alcohol dehydrogenase 1a (class i), alpha polypeptide)
O: alcohol dehydrogenase 4 (class ii), pi polypeptide (homo sapiens) (aka alcohol dehydrogenase 4 (class ii), pi polypeptide)
P: alcohol dehydrogenase 1b (class i), beta polypeptide (xenopus tropicalis) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
Q: None of the above. | [E; H; E; H] |
<Instruct>: Given the context 'There are important amino acid differences in the alcohol-binding site between the human class IV (sigma) and human class I (beta) alcohol dehydrogenases that appear to explain the high catalytic efficiency for all-trans-retinol, the high kcat for ethanol, and the low catalytic efficiency for secondary alcohols of sigma-ADH relative to beta 1-ADH.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [class iv (sigma); class i (beta) alcohol dehydrogenases; sigma-adh; beta 1-adh]
<Options>: A: adh1b promoter (homo sapiens) (aka adh1b promoter)
B: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (mus musculus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
C: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (homo sapiens) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
D: alcohol dehydrogenase 1a (class i), alpha polypeptide (homo sapiens) (aka alcohol dehydrogenase 1a (class i), alpha polypeptide)
E: adh1 (homo sapiens) (aka alcohol dehydrogenase 1a (class i), alpha polypeptide)
F: alcohol dehydrogenase adh3 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh3)
G: alcohol dehydrogenase 1b (class i), beta polypeptide (xenopus tropicalis) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
H: sigma1r (homo sapiens) (aka sigma non-opioid intracellular receptor 1)
I: sigma1c (homo sapiens) (aka adaptor related protein complex 1 subunit sigma 3)
J: alcohol dehydrogenase 1b (class i), beta polypeptide (bos taurus) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
K: adh1c (homo sapiens) (aka alcohol dehydrogenase 1c (class i), gamma polypeptide)
L: sigma5 (mus musculus) (aka adaptor-related protein 5 complex, sigma 1 subunit)
M: adh1b (homo sapiens) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
N: sigma3a (homo sapiens) (aka adaptor related protein complex 3 subunit sigma 1)
O: 14-3-3 protein sigma-like (rattus norvegicus) (aka 14-3-3 protein sigma-like)
P: alcohol dehydrogenase adh1 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh1)
Q: adh4 (homo sapiens) (alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (homo sapiens)) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
R: alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (rattus norvegicus) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
S: None of the above. | [Q; M; Q; M] |
<Instruct>: Given the context 'For example, modeling the binding of all-trans-retinol in the human beta 1-ADH structure suggested that coordination of retinol to the active-site zinc is hindered by a loop from residues 114 to 120 that is at the entrance to the alcohol-binding site.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [beta 1-adh]
<Options>: A: alcohol dehydrogenase 1b (class i), beta polypeptide (xenopus tropicalis) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
B: adh1a (homo sapiens) (aka alcohol dehydrogenase 1a (class i), alpha polypeptide)
C: adh1b (bos taurus) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
D: adh1b (homo sapiens) (aka alcohol dehydrogenase 1b (class i), beta polypeptide)
E: adh1c (homo sapiens) (aka alcohol dehydrogenase 1c (class i), gamma polypeptide)
F: None of the above. | [D] |
<Instruct>: Given the context 'The deletion of Gly-117 in human sigma-ADH and a substitution of Leu for the bulky Tyr-110 appear to facilitate retinol access to the active-site zinc.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [sigma-adh]
<Options>: A: adh4 (homo sapiens) (alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide (homo sapiens)) (aka alcohol dehydrogenase 7 (class iv), mu or sigma polypeptide)
B: alcohol dehydrogenase adh3 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh3)
C: alcohol dehydrogenase adh2 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh2)
D: alcohol dehydrogenase 1a (class i), alpha polypeptide (homo sapiens) (aka alcohol dehydrogenase 1a (class i), alpha polypeptide)
E: adh1 (saccharomyces cerevisiae s288c) (aka alcohol dehydrogenase adh1)
F: None of the above. | [A] |
<Instruct>: Given the context 'The first 240 nucleotides in the 5' untranslated region of type I acetyl-CoA-carboxylase mRNA replace the first 100 nucleotides of the (G + C)-rich region of the 5' untranslated region of the type II mRNA.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [type i acetyl-coa-carboxylase]
<Options>: A: acc-1 (homo sapiens) (aka bcl2 related protein a1)
B: methylcrotonyl-coa carboxylase subunit 1 (homo sapiens) (aka methylcrotonyl-coa carboxylase subunit 1)
C: acca (homo sapiens) (acetyl-coa carboxylase alpha (homo sapiens)) (aka acetyl-coa carboxylase alpha)
D: acetoacetyl-coa synthetase (homo sapiens) (aka acetoacetyl-coa synthetase)
E: acetyl-coa carboxylase 1 (arabidopsis thaliana) (aka acetyl-coa carboxylase 1)
F: None of the above. | [C] |
<Instruct>: Given the context 'Human mu opiate receptor.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mu opiate receptor]
<Options>: A: opioid growth factor receptor (mus musculus) (aka opioid growth factor receptor)
B: opioid related nociceptin receptor 1 (homo sapiens) (aka opioid related nociceptin receptor 1)
C: opioid receptor, mu 1 (mus musculus) (aka opioid receptor, mu 1)
D: opioid receptor-like 1 (mus musculus) (aka opioid receptor-like 1)
E: opioid receptor mu 1 (homo sapiens) (aka opioid receptor mu 1)
F: None of the above. | [E] |
<Instruct>: Given the context 'A human mu opiate receptor cDNA has been identified from a cerebral cortical cDNA library using sequences from the rat mu opiate receptor cDNA.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mu opiate receptor]
<Options>: A: opioid receptor-like 1 (mus musculus) (aka opioid receptor-like 1)
B: opioid growth factor receptor (mus musculus) (aka opioid growth factor receptor)
C: oprm1 (mus musculus) (aka opioid receptor, mu 1)
D: opioid receptor mu 1 (homo sapiens) (aka opioid receptor mu 1)
E: opioid receptor, mu 1 (rattus norvegicus) (aka opioid receptor, mu 1)
F: None of the above. | [D] |
<Instruct>: Given the context 'The human mu opiate receptor (h mu OR1) shares 95% amino acid identity with the rat sequence.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mu opiate receptor; h mu or1]
<Options>: A: nop (mus musculus) (opioid receptor-like 1 (mus musculus)) (aka opioid receptor-like 1)
B: opioid growth factor receptor (mus musculus) (aka opioid growth factor receptor)
C: or51h1 (mus musculus) (aka olfactory receptor family 51 subfamily h member 1)
D: or1m1 (homo sapiens) (aka olfactory receptor family 1 subfamily m member 1)
E: opioid related nociceptin receptor 1 (homo sapiens) (aka opioid related nociceptin receptor 1)
F: opioid receptor mu 1 (homo sapiens) (aka opioid receptor mu 1)
G: or1a1 (mus musculus) (aka olfactory receptor family 1 subfamily a member 1)
H: or1o1 (mus musculus) (aka olfactory receptor family 1 subfamily o member 1)
I: opioid related nociceptin receptor 1 (rattus norvegicus) (aka opioid related nociceptin receptor 1)
J: None of the above. | [F; F] |
<Instruct>: Given the context 'The human mu opiate receptor (h mu OR1) shares 95% amino acid identity with the rat sequence.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mu opiate receptor; h mu or1]
<Options>: A: opioid receptor, mu 1 (rattus norvegicus) (aka opioid receptor, mu 1)
B: opioid related nociceptin receptor 1 (homo sapiens) (aka opioid related nociceptin receptor 1)
C: oprm1 (mus musculus) (aka opioid receptor, mu 1)
D: opioid receptor mu 1 (homo sapiens) (aka opioid receptor mu 1)
E: opioid related nociceptin receptor 1 (rattus norvegicus) (aka opioid related nociceptin receptor 1)
F: or10h1 (mus musculus) (aka olfactory receptor family 10 subfamily h member 1)
G: or1a1 (mus musculus) (aka olfactory receptor family 1 subfamily a member 1)
H: or1m1 (homo sapiens) (aka olfactory receptor family 1 subfamily m member 1)
I: or1o1 (mus musculus) (aka olfactory receptor family 1 subfamily o member 1)
J: None of the above. | [D; D] |
<Instruct>: Given the context 'The human mu opiate receptor (h mu OR1) shares 95% amino acid identity with the rat sequence.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mu opiate receptor; h mu or1]
<Options>: A: oprm1 (mus musculus) (aka opioid receptor, mu 1)
B: or1o1 (mus musculus) (aka olfactory receptor family 1 subfamily o member 1)
C: or1m1 (homo sapiens) (aka olfactory receptor family 1 subfamily m member 1)
D: opioid receptor, mu 1 (rattus norvegicus) (aka opioid receptor, mu 1)
E: opioid related nociceptin receptor 1 (homo sapiens) (aka opioid related nociceptin receptor 1)
F: or10h1 (mus musculus) (aka olfactory receptor family 10 subfamily h member 1)
G: or1a1 (mus musculus) (aka olfactory receptor family 1 subfamily a member 1)
H: opioid related nociceptin receptor 1 (rattus norvegicus) (aka opioid related nociceptin receptor 1)
I: None of the above. | [I; I] |
<Instruct>: Given the context 'The expressed mu OR1 recognized tested opiate drugs and opioid peptides in a sodium- and GTP-sensitive fashion with affinities virtually identical to those displayed by the rat mu opiate receptor.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mu or1; mu opiate receptor]
<Options>: A: opioid growth factor receptor (mus musculus) (aka opioid growth factor receptor)
B: or1o1 (mus musculus) (aka olfactory receptor family 1 subfamily o member 1)
C: or1a1 (mus musculus) (aka olfactory receptor family 1 subfamily a member 1)
D: opioid receptor, mu 1 (rattus norvegicus) (aka opioid receptor, mu 1)
E: opioid receptor, mu 1 (mus musculus) (aka opioid receptor, mu 1)
F: opioid receptor mu 1 (homo sapiens) (aka opioid receptor mu 1)
G: or1r1 (mus musculus) (aka olfactory receptor family 1 subfamily jrmember 1)
H: or-1 (mus musculus) (aka nuclear receptor subfamily 1, group h, member 2)
I: or1af1 (mus musculus) (aka olfactory receptor family 1 subfamily af member 1)
J: opioid related nociceptin receptor 1 (rattus norvegicus) (aka opioid related nociceptin receptor 1)
K: None of the above. | [K; J] |
<Instruct>: Given the context 'The expressed mu OR1 recognized tested opiate drugs and opioid peptides in a sodium- and GTP-sensitive fashion with affinities virtually identical to those displayed by the rat mu opiate receptor.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mu or1; mu opiate receptor]
<Options>: A: or1n1 (mus musculus) (aka olfactory receptor family 1 subfamily n member 1)
B: or1r1 (mus musculus) (aka olfactory receptor family 1 subfamily jrmember 1)
C: opioid related nociceptin receptor 1 (homo sapiens) (aka opioid related nociceptin receptor 1)
D: opr (mus musculus) (aka zinc finger protein of the cerebellum 5)
E: opioid related nociceptin receptor 1 (rattus norvegicus) (aka opioid related nociceptin receptor 1)
F: or1af1 (mus musculus) (aka olfactory receptor family 1 subfamily af member 1)
G: opioid receptor, mu 1 (rattus norvegicus) (aka opioid receptor, mu 1)
H: m-or-1 (mus musculus) (aka opioid receptor, mu 1)
I: opioid growth factor receptor (mus musculus) (aka opioid growth factor receptor)
J: orm-1 (mus musculus) (aka orosomucoid 1)
K: None of the above. | [K; E] |
<Instruct>: Given the context 'Effects on cyclic AMP are similar to those noted for the rat mu opiate receptor.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [mu opiate receptor]
<Options>: A: opioid growth factor receptor (mus musculus) (aka opioid growth factor receptor)
B: oprm1 (mus musculus) (aka opioid receptor, mu 1)
C: opioid receptor, mu 1 (rattus norvegicus) (aka opioid receptor, mu 1)
D: opioid related nociceptin receptor 1 (rattus norvegicus) (aka opioid related nociceptin receptor 1)
E: opioid receptor-like 1 (mus musculus) (aka opioid receptor-like 1)
F: None of the above. | [D] |
<Instruct>: Given the context 'An 18 kb genomic clone hybridizing with the h mu OR1 cDNA contains 63 and 489 bp exonic sequences flanked by splice donor/acceptor sequences.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [h mu or1]
<Options>: A: or1a1 (mus musculus) (aka olfactory receptor family 1 subfamily a member 1)
B: or1o1 (mus musculus) (aka olfactory receptor family 1 subfamily o member 1)
C: or1m1 (homo sapiens) (aka olfactory receptor family 1 subfamily m member 1)
D: or51h1 (mus musculus) (aka olfactory receptor family 51 subfamily h member 1)
E: m-or-1 (homo sapiens) (aka opioid receptor mu 1)
F: None of the above. | [E] |
<Instruct>: Given the context 'Human cytoplasmic 3-hydroxy-3-methylglutaryl coenzyme A synthase: expression, purification, and characterization of recombinant wild-type and Cys129 mutant enzymes.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [cytoplasmic 3-hydroxy-3-methylglutaryl coenzyme a synthase]
<Options>: A: 3-hydroxy-3-methylglutaryl-coa synthase 1 (homo sapiens) (aka 3-hydroxy-3-methylglutaryl-coa synthase 1)
B: 3-hydroxy-3-methylglutaryl-coa lyase (homo sapiens) (aka 3-hydroxy-3-methylglutaryl-coa lyase)
C: 3-oxoacyl-acp synthase, mitochondrial (homo sapiens) (aka 3-oxoacyl-acp synthase, mitochondrial)
D: 3-hydroxy-3-methylglutaryl-coenzyme a synthase 1 (soluble) pseudogene (homo sapiens) (aka 3-hydroxy-3-methylglutaryl-coenzyme a synthase 1 (soluble) pseudogene)
E: 3-hydroxy-3-methylglutaryl-coenzyme a synthase 1 (mus musculus) (aka 3-hydroxy-3-methylglutaryl-coenzyme a synthase 1)
F: None of the above. | [A] |
<Instruct>: Given the context 'A cDNA for the human cytoplasmic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase (EC 4.1.3.5) was subcloned and expressed from a T7-based vector in Escherichia coli.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [cytoplasmic 3-hydroxy-3-methylglutaryl coenzyme a (hmg-coa) synthase]
<Options>: A: 3-hydroxy-3-methylglutaryl-coa synthase 1 (sus scrofa) (aka 3-hydroxy-3-methylglutaryl-coa synthase 1)
B: 3-hydroxy-3-methylglutaryl-coa lyase (homo sapiens) (aka 3-hydroxy-3-methylglutaryl-coa lyase)
C: 3-hydroxy-3-methylglutaryl-coa synthase 1 (homo sapiens) (aka 3-hydroxy-3-methylglutaryl-coa synthase 1)
D: 3-hydroxy-3-methylglutaryl-coa reductase (homo sapiens) (aka 3-hydroxy-3-methylglutaryl-coa reductase)
E: 3-hydroxy-3-methylglutaryl-coenzyme a synthase 1 (soluble) pseudogene (homo sapiens) (aka 3-hydroxy-3-methylglutaryl-coenzyme a synthase 1 (soluble) pseudogene)
F: None of the above. | [C] |
<Instruct>: Given the context 'Association between atopy and variants of the beta subunit of the high-affinity immunoglobulin E receptor.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [beta subunit of the high-affinity immunoglobulin e receptor]
<Options>: A: er-beta (homo sapiens) (aka estrogen receptor 2)
B: endothelin receptor type b (homo sapiens) (aka endothelin receptor type b)
C: cd179b (homo sapiens) (aka immunoglobulin lambda like polypeptide 1)
D: estrogen related receptor beta (bos taurus) (aka estrogen related receptor beta)
E: cd99b (homo sapiens) (aka cd99 molecule like 2)
F: None of the above. | [F] |
<Instruct>: Given the context 'The beta-subunit of the high-affinity IgE receptor (Fc epsilon RI-beta) on chromosome 11 is maternally linked to atopy, the state of enhanced IgE responsiveness underlying allergic asthma and rhinitis.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [beta-subunit of the high-affinity ige receptor; fc epsilon ri-beta]
<Options>: A: cd1b molecule (homo sapiens) (aka cd1b molecule)
B: cd64b (homo sapiens) (aka fc gamma receptor ib, pseudogene)
C: igb (homo sapiens) (aka cd79b molecule)
D: cd99b (homo sapiens) (aka cd99 molecule like 2)
E: fc epsilon receptor ii (homo sapiens) (aka fc epsilon receptor ii)
F: fcgammariic (homo sapiens) (aka fc gamma receptor iic (gene/pseudogene))
G: cd16b (homo sapiens) (aka fc gamma receptor iiib)
H: fcgammariia (homo sapiens) (aka fc gamma receptor iia)
I: cd179b (homo sapiens) (aka immunoglobulin lambda like polypeptide 1)
J: cd79b (bos taurus) (aka cd79b molecule)
K: None of the above. | [K; K] |
<Instruct>: Given the context 'The beta-subunit of the high-affinity IgE receptor (Fc epsilon RI-beta) on chromosome 11 is maternally linked to atopy, the state of enhanced IgE responsiveness underlying allergic asthma and rhinitis.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [beta-subunit of the high-affinity ige receptor; fc epsilon ri-beta]
<Options>: A: cd79b molecule (homo sapiens) (aka cd79b molecule)
B: fc gamma receptor iib (homo sapiens) (aka fc gamma receptor iib)
C: cd179b (homo sapiens) (aka immunoglobulin lambda like polypeptide 1)
D: cd1b molecule (homo sapiens) (aka cd1b molecule)
E: cd99b (homo sapiens) (aka cd99 molecule like 2)
F: fcgammariia (homo sapiens) (aka fc gamma receptor iia)
G: cd16b (homo sapiens) (aka fc gamma receptor iiib)
H: fc epsilon receptor ii (homo sapiens) (aka fc epsilon receptor ii)
I: fcgammariic (homo sapiens) (aka fc gamma receptor iic (gene/pseudogene))
J: cd79b (bos taurus) (aka cd79b molecule)
K: None of the above. | [K; K] |
<Instruct>: Given the context 'We have identified a common variant of Fc epsilon RI-beta, lle181Leu within the 4th transmembrane domain.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [fc epsilon ri-beta]
<Options>: A: cd64b (homo sapiens) (aka fc gamma receptor ib, pseudogene)
B: fcgammariib (homo sapiens) (aka fc gamma receptor iib)
C: fc epsilon receptor ii (homo sapiens) (aka fc epsilon receptor ii)
D: fcgammariic (homo sapiens) (aka fc gamma receptor iic (gene/pseudogene))
E: fcriiib (homo sapiens) (aka fc gamma receptor iiib)
F: None of the above. | [F] |
<Instruct>: Given the context 'Our data indicate that Fc epsilon RI-beta, subject to maternal modification, may be the atopy-causing locus on chromosome 11q.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [fc epsilon ri-beta]
<Options>: A: fcgammariia (homo sapiens) (aka fc gamma receptor iia)
B: fc gamma receptor iib (homo sapiens) (aka fc gamma receptor iib)
C: cd64b (homo sapiens) (aka fc gamma receptor ib, pseudogene)
D: fcgammariic (homo sapiens) (aka fc gamma receptor iic (gene/pseudogene))
E: fcriiib (homo sapiens) (aka fc gamma receptor iiib)
F: None of the above. | [F] |
<Instruct>: Given the context 'Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [thyrotropin receptor]
<Options>: A: thyrotropin releasing hormone receptor (homo sapiens) (aka thyrotropin releasing hormone receptor)
B: thyroid stimulating hormone receptor (rattus norvegicus) (aka thyroid stimulating hormone receptor)
C: tshr (homo sapiens) (aka thyroid stimulating hormone receptor)
D: tshr (bos taurus) (aka thyroid stimulating hormone receptor)
E: thyrotropin releasing hormone receptor (gallus gallus) (aka thyrotropin releasing hormone receptor)
F: None of the above. | [C] |
<Instruct>: Given the context 'The thyrotropin receptor (TSHR), a member of the large family of G protein-coupled receptors, controls both the function and growth of thyroid cells via stimulation of adenylyl cyclase.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [thyrotropin receptor; tshr]
<Options>: A: thyrotropin releasing hormone receptor (rattus norvegicus) (aka thyrotropin releasing hormone receptor)
B: tshb (homo sapiens) (aka thyroid stimulating hormone subunit beta)
C: thyrotropin-releasing hormone receptor (bos taurus) (aka thyrotropin-releasing hormone receptor)
D: tshr (rattus norvegicus) (aka thyroid stimulating hormone receptor)
E: trh-r (homo sapiens) (aka thyrotropin releasing hormone receptor)
F: tshr (homo sapiens) (aka thyroid stimulating hormone receptor)
G: thyrotropin releasing hormone receptor (bos taurus) (aka thyrotropin releasing hormone receptor)
H: thyrotropin releasing hormone receptor (gallus gallus) (aka thyrotropin releasing hormone receptor)
I: None of the above. | [F; F] |
<Instruct>: Given the context 'The thyrotropin receptor (TSHR), a member of the large family of G protein-coupled receptors, controls both the function and growth of thyroid cells via stimulation of adenylyl cyclase.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [thyrotropin receptor; tshr]
<Options>: A: thyrotropin releasing hormone receptor (homo sapiens) (aka thyrotropin releasing hormone receptor)
B: thyrotropin-releasing hormone receptor (bos taurus) (aka thyrotropin-releasing hormone receptor)
C: tshr (homo sapiens) (aka thyroid stimulating hormone receptor)
D: thyrotropin releasing hormone receptor (rattus norvegicus) (aka thyrotropin releasing hormone receptor)
E: thyrotropin releasing hormone receptor (bos taurus) (aka thyrotropin releasing hormone receptor)
F: tshr (rattus norvegicus) (aka thyroid stimulating hormone receptor)
G: thyroid stimulating hormone receptor (rattus norvegicus) (aka thyroid stimulating hormone receptor)
H: thyrotropin releasing hormone receptor (gallus gallus) (aka thyrotropin releasing hormone receptor)
I: None of the above. | [C; C] |
<Instruct>: Given the context 'The thyrotropin receptor (TSHR), a member of the large family of G protein-coupled receptors, controls both the function and growth of thyroid cells via stimulation of adenylyl cyclase.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [thyrotropin receptor; tshr]
<Options>: A: thyroid stimulating hormone receptor (rattus norvegicus) (aka thyroid stimulating hormone receptor)
B: thyrotropin releasing hormone receptor (rattus norvegicus) (aka thyrotropin releasing hormone receptor)
C: thyrotropin-releasing hormone receptor (bos taurus) (aka thyrotropin-releasing hormone receptor)
D: thyrotropin releasing hormone receptor (bos taurus) (aka thyrotropin releasing hormone receptor)
E: thyrotropin releasing hormone receptor (gallus gallus) (aka thyrotropin releasing hormone receptor)
F: tshr (rattus norvegicus) (aka thyroid stimulating hormone receptor)
G: thyrotropin releasing hormone receptor (homo sapiens) (aka thyrotropin releasing hormone receptor)
H: None of the above. | [H; H] |
<Instruct>: Given the context 'We report two different mutations in the TSHR gene of affected members of two large pedigrees with non-autoimmune autosomal dominant hyperthyroidism (toxic thyroid hyperplasia), that involve residues in the third (Val509Ala) and seventh (Cys672Tyr) transmembrane segments.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [tshr]
<Options>: A: trh-r (homo sapiens) (aka thyrotropin releasing hormone receptor)
B: thyrotropin releasing hormone receptor (bos taurus) (aka thyrotropin releasing hormone receptor)
C: thyroid stimulating hormone receptor (homo sapiens) (aka thyroid stimulating hormone receptor)
D: tshb (homo sapiens) (aka thyroid stimulating hormone subunit beta)
E: tshr (bos taurus) (aka thyroid stimulating hormone receptor)
F: None of the above. | [C] |
<Instruct>: Given the context 'X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [l1]
<Options>: A: l1 cell adhesion molecule (homo sapiens) (aka l1 cell adhesion molecule)
B: adhesion g protein-coupled receptor l1 (homo sapiens) (aka adhesion g protein-coupled receptor l1)
C: cyclin l1 (homo sapiens) (aka cyclin l1)
D: l1 cell adhesion molecule (xenopus tropicalis) (aka l1 cell adhesion molecule)
E: l1 (drosophila melanogaster) (retroactive (drosophila melanogaster)) (aka retroactive)
F: None of the above. | [A] |
<Instruct>: Given the context 'We have previously shown that X-linked hydrocephalus is caused by mutations in the gene for neural cell adhesion molecule L1 (L1CAM), an axonal glycoprotein involved in neuronal migration and differentiation.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [neural cell adhesion molecule l1; l1cam]
<Options>: A: n-cam-l1 (homo sapiens) (aka l1 cell adhesion molecule)
B: l1cam (gallus gallus) (aka l1 cell adhesion molecule)
C: n-cam-l1 (mus musculus) (aka l1 cell adhesion molecule)
D: neural cell adhesion molecule 1 (homo sapiens) (aka neural cell adhesion molecule 1)
E: cell adhesion molecule l1 like (homo sapiens) (aka cell adhesion molecule l1 like)
F: cell adhesion molecule l1-like (rattus norvegicus) (aka cell adhesion molecule l1-like)
G: l1cam (mus musculus) (aka l1 cell adhesion molecule)
H: None of the above. | [A; A] |
<Instruct>: Given the context 'We have previously shown that X-linked hydrocephalus is caused by mutations in the gene for neural cell adhesion molecule L1 (L1CAM), an axonal glycoprotein involved in neuronal migration and differentiation.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [neural cell adhesion molecule l1; l1cam]
<Options>: A: cell adhesion molecule l1 like (homo sapiens) (aka cell adhesion molecule l1 like)
B: adhesion g protein-coupled receptor l1 (homo sapiens) (aka adhesion g protein-coupled receptor l1)
C: l1cam (mus musculus) (aka l1 cell adhesion molecule)
D: n-cam-l1 (mus musculus) (aka l1 cell adhesion molecule)
E: l1cam (gallus gallus) (aka l1 cell adhesion molecule)
F: n-caml1 (homo sapiens) (aka l1 cell adhesion molecule)
G: cell adhesion molecule l1-like (rattus norvegicus) (aka cell adhesion molecule l1-like)
H: None of the above. | [F; F] |
<Instruct>: Given the context 'Here we report mutations of the L1 gene in MASA syndrome and SPG1, in addition to HSAS families.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [l1]
<Options>: A: l1 cell adhesion molecule (xenopus tropicalis) (aka l1 cell adhesion molecule)
B: l1 (drosophila melanogaster) (retroactive (drosophila melanogaster)) (aka retroactive)
C: lethal (1) l1 (drosophila melanogaster) (aka lethal (1) l1)
D: l1 cell adhesion molecule (homo sapiens) (aka l1 cell adhesion molecule)
E: cyclin l1 (homo sapiens) (aka cyclin l1)
F: None of the above. | [D] |
<Instruct>: Given the context 'Two of the HSAS mutations would abolish cell surface expression of L1 and represent the first functional null mutations in this disorder.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [l1]
<Options>: A: adhesion g protein-coupled receptor l1 (homo sapiens) (aka adhesion g protein-coupled receptor l1)
B: l(1)l1 (drosophila melanogaster) (lethal (1) l1 (drosophila melanogaster)) (aka lethal (1) l1)
C: l1 cell adhesion molecule (xenopus tropicalis) (aka l1 cell adhesion molecule)
D: l1 cell adhesion molecule (homo sapiens) (aka l1 cell adhesion molecule)
E: cell adhesion molecule l1-like (xenopus tropicalis) (aka cell adhesion molecule l1-like)
F: None of the above. | [D] |
<Instruct>: Given the context 'Our results indicate that these three syndromes from part of a clinical spectrum resulting from a heterogeneous group of mutations in the L1 gene.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [l1]
<Options>: A: cell adhesion molecule l1-like (xenopus tropicalis) (aka cell adhesion molecule l1-like)
B: l1 cell adhesion molecule (homo sapiens) (aka l1 cell adhesion molecule)
C: l1 (drosophila melanogaster) (retroactive (drosophila melanogaster)) (aka retroactive)
D: l1 cell adhesion molecule (xenopus tropicalis) (aka l1 cell adhesion molecule)
E: cyclin l1 (homo sapiens) (aka cyclin l1)
F: None of the above. | [B] |
<Instruct>: Given the context 'Bradykinin induces translocation of the protein kinase C isoforms alpha, epsilon, and zeta.
Bradykinin exerts a broad spectrum of cellular effects on different tissues.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bradykinin]
<Options>: A: kininogen 1 (bos taurus) (aka kininogen 1)
B: bradykinin (xenopus tropicalis) (aka bradykinin receptor b2)
C: bradykinin receptor b2 (homo sapiens) (aka bradykinin receptor b2)
D: kallikrein 1 (bos taurus) (aka kallikrein 1)
E: bk (homo sapiens) (aka kininogen 1)
F: None of the above. | [E] |
<Instruct>: Given the context 'Bradykinin induces translocation of the protein kinase C isoforms alpha, epsilon, and zeta.
Bradykinin exerts a broad spectrum of cellular effects on different tissues.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bradykinin]
<Options>: A: kallikrein 1 (bos taurus) (aka kallikrein 1)
B: bradykinin receptor b2 (homo sapiens) (aka bradykinin receptor b2)
C: bradykinin (xenopus tropicalis) (aka bradykinin receptor b2)
D: kininogen 1 (bos taurus) (aka kininogen 1)
E: None of the above. | [E] |
<Instruct>: Given the context 'It is believed that these effects are predominantly mediated by the recently cloned B2 receptor.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b2 receptor]
<Options>: A: bdkrb2 (homo sapiens) (aka bradykinin receptor b2)
B: blr2 (homo sapiens) (aka c-c motif chemokine receptor 7)
C: bkb1r (homo sapiens) (aka bradykinin receptor b1)
D: bb2r (homo sapiens) (aka gastrin releasing peptide receptor)
E: adrb2r (homo sapiens) (aka adrenoceptor beta 2)
F: None of the above. | [A] |
<Instruct>: Given the context 'Involvement of protein kinase C (PKC) was suggested and activation of the classical PKC isoforms alpha and beta was recently demonstrated.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [pkc isoforms alpha]
<Options>: A: protein kinase c, alpha (xenopus tropicalis) (aka protein kinase c, alpha)
B: protein kinase camp-activated catalytic subunit alpha (homo sapiens) (aka protein kinase camp-activated catalytic subunit alpha)
C: protein kinase c iota (homo sapiens) (aka protein kinase c iota)
D: pkcalpha (homo sapiens) (aka protein kinase c alpha)
E: prkaa (homo sapiens) (aka protein kinase amp-activated catalytic subunit alpha 2)
F: None of the above. | [D] |
<Instruct>: Given the context 'The aim of the present study was to investigate whether the B2 receptor also activates new (delta, epsilon) and atypical (zeta) PKC isoforms.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b2 receptor]
<Options>: A: bkb1r (homo sapiens) (aka bradykinin receptor b1)
B: blr2 (homo sapiens) (aka c-c motif chemokine receptor 7)
C: bb2r (homo sapiens) (aka gastrin releasing peptide receptor)
D: bradykinin receptor b2 (homo sapiens) (aka bradykinin receptor b2)
E: adrb2 (homo sapiens) (aka adrenoceptor beta 2)
F: None of the above. | [D] |
<Instruct>: Given the context 'To investigate this, chinese hamster ovary (CHO) cells, stably transfected with human B2 receptor, were used.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b2 receptor]
<Options>: A: bradykinin receptor b2 (homo sapiens) (aka bradykinin receptor b2)
B: adrb2 (homo sapiens) (aka adrenoceptor beta 2)
C: blr2 (homo sapiens) (aka c-c motif chemokine receptor 7)
D: bkb1r (homo sapiens) (aka bradykinin receptor b1)
E: bb2r (homo sapiens) (aka gastrin releasing peptide receptor)
F: None of the above. | [A] |
<Instruct>: Given the context 'Stimulation of the cells with bradykinin resulted in a rapid (30-60 s) translocation of the PKC isoforms alpha, epsilon, and zeta.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bradykinin]
<Options>: A: bradykinin (xenopus tropicalis) (aka bradykinin receptor b2)
B: kallikrein (homo sapiens) (aka kallikrein related peptidase 4)
C: bradykinin receptor b1 (homo sapiens) (aka bradykinin receptor b1)
D: kallikrein b1 (bos taurus) (aka kallikrein b1)
E: bk (homo sapiens) (aka kininogen 1)
F: None of the above. | [E] |
<Instruct>: Given the context 'Translocation of PKC delta was not detected.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [pkc delta]
<Options>: A: npkc-delta (homo sapiens) (aka protein kinase c delta)
B: pkcd (drosophila melanogaster) (aka protein kinase c delta)
C: protein kinase c delta (xenopus tropicalis) (aka protein kinase c delta)
D: protein kinase c delta (bos taurus) (aka protein kinase c delta)
E: None of the above. | [A] |
<Instruct>: Given the context 'The effect of bradykinin was reduced by simultaneous addition of the receptor antagonist HOE 140, a bradykinin-related decapeptide.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [bradykinin]
<Options>: A: bk (homo sapiens) (aka kininogen 1)
B: bradykinin (xenopus tropicalis) (aka bradykinin receptor b2)
C: bradykinin (xenopus laevis) (bradykinin receptor b2 s homeolog (xenopus laevis)) (aka bradykinin receptor b2 s homeolog)
D: bradykinin receptor b2 (homo sapiens) (aka bradykinin receptor b2)
E: kallikrein (homo sapiens) (aka kallikrein related peptidase 4)
F: None of the above. | [A] |
<Instruct>: Given the context 'The data show that the B2 receptor in this cell model is able to activate, in addition to the classical PKC isoform alpha, the new PKC isoform epsilon and the atypical PKC isoform zeta.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b2 receptor; pkc isoform alpha; pkc isoform epsilon; pkc isoform zeta]
<Options>: A: protein kinase c epsilon (sus scrofa) (aka protein kinase c epsilon)
B: prkaca (homo sapiens) (protein kinase camp-activated catalytic subunit alpha (homo sapiens)) (aka protein kinase camp-activated catalytic subunit alpha)
C: protein kinase c, alpha (xenopus tropicalis) (aka protein kinase c, alpha)
D: bkb1r (homo sapiens) (aka bradykinin receptor b1)
E: prkaca (homo sapiens) (protein kinase c alpha (homo sapiens)) (aka protein kinase c alpha)
F: protein kinase c, epsilon (rattus norvegicus) (aka protein kinase c, epsilon)
G: bb2r (homo sapiens) (aka gastrin releasing peptide receptor)
H: protein kinase c zeta (bos taurus) (aka protein kinase c zeta)
I: blr2 (homo sapiens) (aka c-c motif chemokine receptor 7)
J: protein kinase c epsilon (bos taurus) (aka protein kinase c epsilon)
K: protein kinase c, zeta (mus musculus) (aka protein kinase c, zeta)
L: protein kinase c eta (homo sapiens) (aka protein kinase c eta)
M: protein kinase c zeta (homo sapiens) (aka protein kinase c zeta)
N: pkc-zeta (xenopus laevis) (protein kinase c zeta s homeolog (xenopus laevis)) (aka protein kinase c zeta s homeolog)
O: pkn-alpha (homo sapiens) (aka protein kinase n1)
P: protein kinase c, zeta (rattus norvegicus) (aka protein kinase c, zeta)
Q: prkaa (homo sapiens) (aka protein kinase amp-activated catalytic subunit alpha 2)
R: protein kinase c epsilon (homo sapiens) (aka protein kinase c epsilon)
S: bdkrb2 (homo sapiens) (aka bradykinin receptor b2)
T: b2ar (homo sapiens) (aka adrenoceptor beta 2)
U: None of the above. | [S; E; R; M] |
<Instruct>: Given the context 'The data show that the B2 receptor in this cell model is able to activate, in addition to the classical PKC isoform alpha, the new PKC isoform epsilon and the atypical PKC isoform zeta.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b2 receptor; pkc isoform alpha; pkc isoform epsilon; pkc isoform zeta]
<Options>: A: pkcalpha (homo sapiens) (aka protein kinase c alpha)
B: protein kinase c epsilon (sus scrofa) (aka protein kinase c epsilon)
C: pkn-alpha (homo sapiens) (aka protein kinase n1)
D: pkc-zeta (xenopus laevis) (protein kinase c zeta l homeolog (xenopus laevis)) (aka protein kinase c zeta l homeolog)
E: prkaa (homo sapiens) (aka protein kinase amp-activated catalytic subunit alpha 2)
F: protein kinase c, alpha (xenopus tropicalis) (aka protein kinase c, alpha)
G: protein kinase c zeta (xenopus tropicalis) (aka protein kinase c zeta)
H: blr2 (homo sapiens) (aka c-c motif chemokine receptor 7)
I: bkb1r (homo sapiens) (aka bradykinin receptor b1)
J: npkc-epsilon (homo sapiens) (aka protein kinase c epsilon)
K: pkc-zeta (homo sapiens) (aka protein kinase c zeta)
L: bb2r (homo sapiens) (aka gastrin releasing peptide receptor)
M: pkc-zeta (xenopus laevis) (protein kinase c zeta s homeolog (xenopus laevis)) (aka protein kinase c zeta s homeolog)
N: protein kinase c, zeta (rattus norvegicus) (aka protein kinase c, zeta)
O: protein kinase c, epsilon (mus musculus) (aka protein kinase c, epsilon)
P: bradykinin receptor b2 (homo sapiens) (aka bradykinin receptor b2)
Q: protein kinase c, epsilon (rattus norvegicus) (aka protein kinase c, epsilon)
R: protein kinase camp-activated catalytic subunit alpha (homo sapiens) (aka protein kinase camp-activated catalytic subunit alpha)
S: adrb2 (homo sapiens) (aka adrenoceptor beta 2)
T: pkc-epsilon (xenopus tropicalis) (aka protein kinase c epsilon)
U: None of the above. | [P; A; J; K] |
<Instruct>: Given the context 'The data show that the B2 receptor in this cell model is able to activate, in addition to the classical PKC isoform alpha, the new PKC isoform epsilon and the atypical PKC isoform zeta.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b2 receptor; pkc isoform alpha; pkc isoform epsilon; pkc isoform zeta]
<Options>: A: protein kinase c, epsilon (mus musculus) (aka protein kinase c, epsilon)
B: prkaa (homo sapiens) (aka protein kinase amp-activated catalytic subunit alpha 2)
C: blr2 (homo sapiens) (aka c-c motif chemokine receptor 7)
D: pkn-alpha (homo sapiens) (aka protein kinase n1)
E: protein kinase c zeta (xenopus tropicalis) (aka protein kinase c zeta)
F: protein kinase c, zeta (rattus norvegicus) (aka protein kinase c, zeta)
G: protein kinase c, epsilon (rattus norvegicus) (aka protein kinase c, epsilon)
H: protein kinase c zeta (bos taurus) (aka protein kinase c zeta)
I: prkaca (homo sapiens) (protein kinase camp-activated catalytic subunit alpha (homo sapiens)) (aka protein kinase camp-activated catalytic subunit alpha)
J: bb2r (homo sapiens) (aka gastrin releasing peptide receptor)
K: protein kinase c, alpha (xenopus tropicalis) (aka protein kinase c, alpha)
L: bradykinin receptor b2 (homo sapiens) (aka bradykinin receptor b2)
M: protein kinase c, zeta (mus musculus) (aka protein kinase c, zeta)
N: b2ar (homo sapiens) (aka adrenoceptor beta 2)
O: protein kinase c epsilon (bos taurus) (aka protein kinase c epsilon)
P: prkaca (homo sapiens) (protein kinase c alpha (homo sapiens)) (aka protein kinase c alpha)
Q: pkc-epsilon (xenopus tropicalis) (aka protein kinase c epsilon)
R: protein kinase c zeta (homo sapiens) (aka protein kinase c zeta)
S: bkb1r (homo sapiens) (aka bradykinin receptor b1)
T: npkc-epsilon (homo sapiens) (aka protein kinase c epsilon)
U: None of the above. | [L; P; T; R] |
<Instruct>: Given the context 'The data show that the B2 receptor in this cell model is able to activate, in addition to the classical PKC isoform alpha, the new PKC isoform epsilon and the atypical PKC isoform zeta.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b2 receptor; pkc isoform alpha; pkc isoform epsilon; pkc isoform zeta]
<Options>: A: bkb1r (homo sapiens) (aka bradykinin receptor b1)
B: pkcalpha (homo sapiens) (aka protein kinase c alpha)
C: pkce (homo sapiens) (aka protein kinase c epsilon)
D: protein kinase camp-activated catalytic subunit alpha (homo sapiens) (aka protein kinase camp-activated catalytic subunit alpha)
E: pkc-zeta (xenopus laevis) (protein kinase c zeta l homeolog (xenopus laevis)) (aka protein kinase c zeta l homeolog)
F: protein kinase c epsilon (sus scrofa) (aka protein kinase c epsilon)
G: prkaa (homo sapiens) (aka protein kinase amp-activated catalytic subunit alpha 2)
H: pkc-zeta (xenopus laevis) (protein kinase c zeta s homeolog (xenopus laevis)) (aka protein kinase c zeta s homeolog)
I: protein kinase c, zeta (rattus norvegicus) (aka protein kinase c, zeta)
J: pkn-alpha (homo sapiens) (aka protein kinase n1)
K: adrb2 (homo sapiens) (aka adrenoceptor beta 2)
L: protein kinase c, zeta (mus musculus) (aka protein kinase c, zeta)
M: protein kinase c, epsilon (mus musculus) (aka protein kinase c, epsilon)
N: protein kinase c epsilon (bos taurus) (aka protein kinase c epsilon)
O: protein kinase c, alpha (xenopus tropicalis) (aka protein kinase c, alpha)
P: protein kinase c zeta (homo sapiens) (aka protein kinase c zeta)
Q: bb2r (homo sapiens) (aka gastrin releasing peptide receptor)
R: bradykinin receptor b2 (homo sapiens) (aka bradykinin receptor b2)
S: protein kinase c eta (homo sapiens) (aka protein kinase c eta)
T: blr2 (homo sapiens) (aka c-c motif chemokine receptor 7)
U: None of the above. | [R; B; C; P] |
<Instruct>: Given the context 'In this cell system similar results on PKC alpha, epsilon, and zeta were observed, suggesting that all three PKC isoforms are involved in signal transduction of the B2 receptor.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [b2 receptor]
<Options>: A: bkb1r (homo sapiens) (aka bradykinin receptor b1)
B: bkr2 (homo sapiens) (aka bradykinin receptor b2)
C: b2ar (homo sapiens) (aka adrenoceptor beta 2)
D: bb2r (homo sapiens) (aka gastrin releasing peptide receptor)
E: blr2 (homo sapiens) (aka c-c motif chemokine receptor 7)
F: None of the above. | [B] |
<Instruct>: Given the context 'Protein structure of fetal antigen 1 (FA1).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [fetal antigen 1; fa1]
<Options>: A: faf (homo sapiens) (fa complementation group f (homo sapiens)) (aka fa complementation group f)
B: fa-1 (homo sapiens) (aka small nuclear ribonucleoprotein 13)
C: fmr1 autosomal homolog 1 (homo sapiens) (aka fmr1 autosomal homolog 1)
D: feta (homo sapiens) (alpha fetoprotein (homo sapiens)) (aka alpha fetoprotein)
E: fetal and adult testis expressed 1 (homo sapiens) (aka fetal and adult testis expressed 1)
F: faf1 (homo sapiens) (aka fas associated factor 1)
G: fa1 (homo sapiens) (fa complementation group a (homo sapiens)) (aka fa complementation group a)
H: fet1 (homo sapiens) (aka dopamine receptor d3)
I: fa complementation group i (homo sapiens) (aka fa complementation group i)
J: None of the above. | [J; J] |
<Instruct>: Given the context 'Protein structure of fetal antigen 1 (FA1).', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [fetal antigen 1; fa1]
<Options>: A: fah1 (homo sapiens) (aka fatty acid 2-hydroxylase)
B: faf1 (homo sapiens) (aka fas associated factor 1)
C: fa-1 (homo sapiens) (aka small nuclear ribonucleoprotein 13)
D: fa complementation group i (homo sapiens) (aka fa complementation group i)
E: fmr1 autosomal homolog 1 (homo sapiens) (aka fmr1 autosomal homolog 1)
F: fetal and adult testis expressed 1 (homo sapiens) (aka fetal and adult testis expressed 1)
G: fa1 (homo sapiens) (fa complementation group a (homo sapiens)) (aka fa complementation group a)
H: fmr1 autosomal homolog 1 (danio rerio) (aka fmr1 autosomal homolog 1)
I: fat1 (homo sapiens) (aka fat atypical cadherin 1)
J: faf (homo sapiens) (fa complementation group f (homo sapiens)) (aka fa complementation group f)
K: None of the above. | [K; K] |
<Instruct>: Given the context 'A novel circulating human epidermal-growth-factor-like protein expressed in neuroendocrine tumors and its relation to the gene products of dlk and pG2.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [dlk; pg2]
<Options>: A: dlk (drosophila melanogaster) (leucokinin (drosophila melanogaster)) (aka leucokinin)
B: dlk2 (homo sapiens) (aka delta like non-canonical notch ligand 2)
C: dlk-1 (homo sapiens) (aka delta like non-canonical notch ligand 1)
D: dlk-1 (rattus norvegicus) (aka delta like non-canonical notch ligand 1)
E: pgm2 (homo sapiens) (aka phosphoglucomutase 2)
F: polygalacturonase pg2 (glycine max) (aka polygalacturonase pg2)
G: phosphoglycerate kinase 2 (homo sapiens) (aka phosphoglycerate kinase 2)
H: pgdp2 (homo sapiens) (aka phosphogluconate dehydrogenase pseudogene 2)
I: dlg (drosophila melanogaster) (discs large 2 (drosophila melanogaster)) (aka discs large 2)
J: None of the above. | [C; C] |
<Instruct>: Given the context 'A novel circulating human epidermal-growth-factor-like protein expressed in neuroendocrine tumors and its relation to the gene products of dlk and pG2.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [dlk; pg2]
<Options>: A: dlk2 (homo sapiens) (aka delta like non-canonical notch ligand 2)
B: phosphoglycerate kinase 2 (homo sapiens) (aka phosphoglycerate kinase 2)
C: dlg (drosophila melanogaster) (discs large 2 (drosophila melanogaster)) (aka discs large 2)
D: pgm2 (homo sapiens) (aka phosphoglucomutase 2)
E: pgdp2 (homo sapiens) (aka phosphogluconate dehydrogenase pseudogene 2)
F: polygalacturonase pg2 (glycine max) (aka polygalacturonase pg2)
G: dlk (drosophila melanogaster) (leucokinin (drosophila melanogaster)) (aka leucokinin)
H: dlk-1 (rattus norvegicus) (aka delta like non-canonical notch ligand 1)
I: None of the above. | [I; I] |
<Instruct>: Given the context 'A novel circulating human epidermal-growth-factor-like protein expressed in neuroendocrine tumors and its relation to the gene products of dlk and pG2.
', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [dlk; pg2]
<Options>: A: pgdp2 (homo sapiens) (aka phosphogluconate dehydrogenase pseudogene 2)
B: pgap2 (homo sapiens) (aka post-gpi attachment to proteins 2)
C: pg2 (mus musculus) (aka delta like non-canonical notch ligand 1)
D: dlk1 (homo sapiens) (aka delta like non-canonical notch ligand 1)
E: dlk (drosophila melanogaster) (leucokinin (drosophila melanogaster)) (aka leucokinin)
F: pgm2 (homo sapiens) (aka phosphoglucomutase 2)
G: dlk-1 (rattus norvegicus) (aka delta like non-canonical notch ligand 1)
H: dlak (drosophila melanogaster) (aka i-kappab kinase beta)
I: dlk/zpk (drosophila melanogaster) (aka wallenda)
J: None of the above. | [D; D] |
<Instruct>: Given the context 'The present paper describes the primary structure, glycosylation and tissue localization of fetal antigen 1 (FA1) isolated from second-trimester human amniotic fluid.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [fetal antigen 1; fa1]
<Options>: A: fa (homo sapiens) (fa complementation group a (homo sapiens)) (aka fa complementation group a)
B: fmr1 autosomal homolog 1 (danio rerio) (aka fmr1 autosomal homolog 1)
C: fah1 (homo sapiens) (aka fatty acid 2-hydroxylase)
D: faf1 (homo sapiens) (aka fas associated factor 1)
E: fa complementation group f (homo sapiens) (aka fa complementation group f)
F: atrial fibrillation, familial 1 (homo sapiens) (aka atrial fibrillation, familial 1)
G: feta (homo sapiens) (alpha fetoprotein (homo sapiens)) (aka alpha fetoprotein)
H: fet1 (homo sapiens) (aka dopamine receptor d3)
I: fa complementation group i (homo sapiens) (aka fa complementation group i)
J: mage family member f1 (homo sapiens) (aka mage family member f1)
K: None of the above. | [K; K] |
<Instruct>: Given the context 'The present paper describes the primary structure, glycosylation and tissue localization of fetal antigen 1 (FA1) isolated from second-trimester human amniotic fluid.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [fetal antigen 1; fa1]
<Options>: A: atrial fibrillation, familial 1 (homo sapiens) (aka atrial fibrillation, familial 1)
B: fmr1 autosomal homolog 1 (danio rerio) (aka fmr1 autosomal homolog 1)
C: fa (homo sapiens) (fa complementation group a (homo sapiens)) (aka fa complementation group a)
D: fa-1 (homo sapiens) (aka small nuclear ribonucleoprotein 13)
E: faf (homo sapiens) (fa complementation group f (homo sapiens)) (aka fa complementation group f)
F: feta (homo sapiens) (alpha fetoprotein (homo sapiens)) (aka alpha fetoprotein)
G: fet1 (homo sapiens) (aka dopamine receptor d3)
H: fah1 (homo sapiens) (aka fatty acid 2-hydroxylase)
I: faf1 (homo sapiens) (aka fas associated factor 1)
J: fam1a (homo sapiens) (aka metallophosphoesterase domain containing 1)
K: None of the above. | [K; K] |
<Instruct>: Given the context 'FA1 is a single-chained, heterogeneous glycoprotein of 225-262 amino acid residues.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [fa1]
<Options>: A: faf (homo sapiens) (fa complementation group f (homo sapiens)) (aka fa complementation group f)
B: fa complementation group i (homo sapiens) (aka fa complementation group i)
C: faf1 (homo sapiens) (aka fas associated factor 1)
D: fa1 (homo sapiens) (fa complementation group a (homo sapiens)) (aka fa complementation group a)
E: fa-1 (homo sapiens) (aka small nuclear ribonucleoprotein 13)
F: None of the above. | [F] |
<Instruct>: Given the context 'FA1 has six well conserved epidermal-growth-factor motifs and contains up to ten O-glycosylation and N-glycosylation sites, six of which are differentially glycosylated.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [fa1]
<Options>: A: faf1 (homo sapiens) (aka fas associated factor 1)
B: fa-1 (homo sapiens) (aka small nuclear ribonucleoprotein 13)
C: faf (homo sapiens) (fa complementation group f (homo sapiens)) (aka fa complementation group f)
D: fah1 (homo sapiens) (aka fatty acid 2-hydroxylase)
E: fa (homo sapiens) (fa complementation group a (homo sapiens)) (aka fa complementation group a)
F: None of the above. | [F] |
<Instruct>: Given the context 'Alignment to the translated sequences of Mus. musculus dlk and human dlk revealed 86% and 99% identity, respectively, to a 259-amino-acid residue overlap, and this high similarity extends with minor corrections to the human adrenal-specific mRNA, pG2 as well.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [dlk; pg2]
<Options>: A: pghs-2 (homo sapiens) (aka prostaglandin-endoperoxide synthase 2)
B: pgk2 (homo sapiens) (phosphoglycerate kinase 1, pseudogene 2 (homo sapiens)) (aka phosphoglycerate kinase 1, pseudogene 2)
C: dlak (drosophila melanogaster) (aka i-kappab kinase beta)
D: dlg (drosophila melanogaster) (discs large 2 (drosophila melanogaster)) (aka discs large 2)
E: dlk2 (homo sapiens) (aka delta like non-canonical notch ligand 2)
F: polygalacturonase pg2 (glycine max) (aka polygalacturonase pg2)
G: pgdp2 (homo sapiens) (aka phosphogluconate dehydrogenase pseudogene 2)
H: dlk-1 (rattus norvegicus) (aka delta like non-canonical notch ligand 1)
I: dlk-1 (homo sapiens) (aka delta like non-canonical notch ligand 1)
J: None of the above. | [I; I] |
<Instruct>: Given the context 'Alignment to the translated sequences of Mus. musculus dlk and human dlk revealed 86% and 99% identity, respectively, to a 259-amino-acid residue overlap, and this high similarity extends with minor corrections to the human adrenal-specific mRNA, pG2 as well.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [dlk; pg2]
<Options>: A: dlak (drosophila melanogaster) (aka i-kappab kinase beta)
B: dlk-1 (rattus norvegicus) (aka delta like non-canonical notch ligand 1)
C: polygalacturonase pg2 (glycine max) (aka polygalacturonase pg2)
D: pghs-2 (homo sapiens) (aka prostaglandin-endoperoxide synthase 2)
E: pgdp2 (homo sapiens) (aka phosphogluconate dehydrogenase pseudogene 2)
F: pgk2 (homo sapiens) (phosphoglycerate kinase 1, pseudogene 2 (homo sapiens)) (aka phosphoglycerate kinase 1, pseudogene 2)
G: dlg (drosophila melanogaster) (discs large 2 (drosophila melanogaster)) (aka discs large 2)
H: dlk2 (homo sapiens) (aka delta like non-canonical notch ligand 2)
I: None of the above. | [I; I] |
<Instruct>: Given the context 'Alignment to the translated sequences of Mus. musculus dlk and human dlk revealed 86% and 99% identity, respectively, to a 259-amino-acid residue overlap, and this high similarity extends with minor corrections to the human adrenal-specific mRNA, pG2 as well.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [dlk; pg2]
<Options>: A: dlk (drosophila melanogaster) (leucokinin (drosophila melanogaster)) (aka leucokinin)
B: dlk-1 (rattus norvegicus) (aka delta like non-canonical notch ligand 1)
C: dlk-2 (homo sapiens) (aka delta like non-canonical notch ligand 2)
D: pgap2 (homo sapiens) (aka post-gpi attachment to proteins 2)
E: phosphoglycerate kinase 2 (homo sapiens) (aka phosphoglycerate kinase 2)
F: dlk/zpk (drosophila melanogaster) (aka wallenda)
G: pgdp2 (homo sapiens) (aka phosphogluconate dehydrogenase pseudogene 2)
H: dlk1 (homo sapiens) (aka delta like non-canonical notch ligand 1)
I: pgm2 (homo sapiens) (aka phosphoglucomutase 2)
J: None of the above. | [H; H] |
<Instruct>: Given the context 'Immunohistochemical analysis demonstrated the presence of FA1 in 10 out of 14 lung tumors containing neuroendocrine elements, and in the placental villi where FA1 was exclusively seen in stromal cells in close contact to the vascular structure.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [fa1]
<Options>: A: fa (homo sapiens) (fa complementation group a (homo sapiens)) (aka fa complementation group a)
B: fa-1 (homo sapiens) (aka small nuclear ribonucleoprotein 13)
C: fah1 (homo sapiens) (aka fatty acid 2-hydroxylase)
D: fa complementation group f (homo sapiens) (aka fa complementation group f)
E: fa complementation group i (homo sapiens) (aka fa complementation group i)
F: None of the above. | [F] |
<Instruct>: Given the context 'In the pancreas, FA1 co-localized with insulin in the insulin secretory granules of the beta cells within the islets of Langerhans.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [fa1]
<Options>: A: fa-1 (homo sapiens) (aka small nuclear ribonucleoprotein 13)
B: faf1 (homo sapiens) (aka fas associated factor 1)
C: fa complementation group a (homo sapiens) (aka fa complementation group a)
D: faf (homo sapiens) (fa complementation group f (homo sapiens)) (aka fa complementation group f)
E: fa complementation group i (homo sapiens) (aka fa complementation group i)
F: None of the above. | [F] |
<Instruct>: Given the context 'Our findings suggest that FA1 is synthesized as a membrane anchored protein and released into the circulation after enzymic cleavage, and that circulating FA1 represents the post-translationally modified gene product of human dlk which, in turn, is identical to human adrenal-specific mRNA pG2.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [fa1; dlk; pg2]
<Options>: A: pgap2 (homo sapiens) (aka post-gpi attachment to proteins 2)
B: ptgs2 (homo sapiens) (aka prostaglandin-endoperoxide synthase 2)
C: pgk2 (homo sapiens) (phosphoglycerate kinase 1, pseudogene 2 (homo sapiens)) (aka phosphoglycerate kinase 1, pseudogene 2)
D: dlak (drosophila melanogaster) (aka i-kappab kinase beta)
E: fa complementation group a (homo sapiens) (aka fa complementation group a)
F: dlg (drosophila melanogaster) (discs large 2 (drosophila melanogaster)) (aka discs large 2)
G: fa complementation group i (homo sapiens) (aka fa complementation group i)
H: dlk2 (homo sapiens) (aka delta like non-canonical notch ligand 2)
I: pgm2 (homo sapiens) (aka phosphoglucomutase 2)
J: fah1 (homo sapiens) (aka fatty acid 2-hydroxylase)
K: dlk/zpk (drosophila melanogaster) (aka wallenda)
L: faf1 (homo sapiens) (aka fas associated factor 1)
M: fa-1 (homo sapiens) (aka small nuclear ribonucleoprotein 13)
N: dlk1 (homo sapiens) (aka delta like non-canonical notch ligand 1)
O: None of the above. | [N; N; N] |
<Instruct>: Given the context 'Our findings suggest that FA1 is synthesized as a membrane anchored protein and released into the circulation after enzymic cleavage, and that circulating FA1 represents the post-translationally modified gene product of human dlk which, in turn, is identical to human adrenal-specific mRNA pG2.', select the correct biomedical concept for each mention using the provided options. Answer by listing the selected options, one for each mention, separated by semicolon. | <Mentions>: [fa1; dlk; pg2]
<Options>: A: pg2 (mus musculus) (aka delta like non-canonical notch ligand 1)
B: dlk1 (homo sapiens) (aka delta like non-canonical notch ligand 1)
C: fa complementation group f (homo sapiens) (aka fa complementation group f)
D: faf1 (homo sapiens) (aka fas associated factor 1)
E: pgk2 (homo sapiens) (phosphoglycerate kinase 1, pseudogene 2 (homo sapiens)) (aka phosphoglycerate kinase 1, pseudogene 2)
F: fa-1 (homo sapiens) (aka small nuclear ribonucleoprotein 13)
G: dlk-1 (rattus norvegicus) (aka delta like non-canonical notch ligand 1)
H: dlk (drosophila melanogaster) (leucokinin (drosophila melanogaster)) (aka leucokinin)
I: dlg (drosophila melanogaster) (discs large 2 (drosophila melanogaster)) (aka discs large 2)
J: fa complementation group i (homo sapiens) (aka fa complementation group i)
K: dlg (drosophila melanogaster) (discs large 1 (drosophila melanogaster)) (aka discs large 1)
L: fa complementation group a (homo sapiens) (aka fa complementation group a)
M: pgdp2 (homo sapiens) (aka phosphogluconate dehydrogenase pseudogene 2)
N: polygalacturonase pg2 (glycine max) (aka polygalacturonase pg2)
O: None of the above. | [B; B; B] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.